Kusajili – Clinical trials directory

Result of your search per specialist: Merck contact

Woman and Man
Between 18 years and 85 years
Merck Sharp & Dohme (MSD) Update Il y a 5 ans

Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanc...

Country France
organs Carcinomes cutanés
Specialty Pharmacologie - Recherche de Transfert

Essai ouvert aux inclusions

More information